MYRIAD GENETICS INC. - COMMON STOCK
14.69
18-February-25 08:57:52
15 minutes delayed
Stocks
+0.13
+0.89%
Today's range
14.46 - 14.90
ISIN
N/A
Source
NASDAQ
-
NetDania - New 12 months Low: MYRIAD GENETICS INC. - COMMON STOCK
13 Dec 2024 08:46:22 By NetDania Notify
-
NetDania - New 12 months Low: MYRIAD GENETICS INC. - COMMON STOCK
12 Dec 2024 08:45:26 By NetDania Notify
-
10 Dec 2024 17:26:39 By Nasdaq GlobeNewswire
-
Myriad Genetics Expands Board of Directors with Election of Mark S. Davis as New Board Member
10 Dec 2024 15:05:00 By Nasdaq GlobeNewswire
-
Myriad Genetics’ Portfolio Elevated by Updated NCCN Prostate Cancer Guidelines
10 Dec 2024 07:00:00 By Nasdaq GlobeNewswire
-
Myriad Genetics to Present New Data at San Antonio Breast Cancer Symposium
09 Dec 2024 15:05:00 By Nasdaq GlobeNewswire
-
09 Dec 2024 07:00:00 By Nasdaq GlobeNewswire
-
NetDania - New 12 months Low: MYRIAD GENETICS INC. - COMMON STOCK
06 Dec 2024 08:53:52 By NetDania Notify
-
20 Nov 2024 15:30:00 By Nasdaq GlobeNewswire
-
NetDania - New 12 months Low: MYRIAD GENETICS INC. - COMMON STOCK
20 Nov 2024 08:52:22 By NetDania Notify
-
NetDania - New 12 months Low: MYRIAD GENETICS INC. - COMMON STOCK
19 Nov 2024 09:20:58 By NetDania Notify
-
19 Nov 2024 07:00:01 By Nasdaq GlobeNewswire
-
NetDania - New 12 months Low: MYRIAD GENETICS INC. - COMMON STOCK
18 Nov 2024 08:46:05 By NetDania Notify
-
NetDania - New 12 months Low: MYRIAD GENETICS INC. - COMMON STOCK
15 Nov 2024 08:49:49 By NetDania Notify
-
NetDania - New 12 months Low: MYRIAD GENETICS INC. - COMMON STOCK
14 Nov 2024 08:54:04 By NetDania Notify
-
NetDania - New 12 months Low: MYRIAD GENETICS INC. - COMMON STOCK
13 Nov 2024 10:10:23 By NetDania Notify
-
Myriad Genetics Expands Access to At-Home Early Fetal Sex DNA Test with Retail Launch
13 Nov 2024 07:00:01 By Nasdaq GlobeNewswire
-
Myriad Genetics Reports Third Quarter 2024 Financial Results; Updates 2024 Financial Guidance
07 Nov 2024 15:05:02 By Nasdaq GlobeNewswire
-
Myriad Genetics Comments on UnitedHealthcare’s Updated Medical Policy for Pharmacogenetic Testing
04 Nov 2024 07:39:37 By Nasdaq GlobeNewswire
-
Myriad Genetics to Release Third Quarter 2024 Financial Results on November 7, 2024
30 Oct 2024 07:00:00 By Nasdaq GlobeNewswire